05:47 PM EDT, 08/04/2025 (MT Newswires) -- Joseph Michael Fitzgerald, Executive Vice President and Group President, Cardiology, on August 01, 2025, sold 50,000 shares in Boston Scientific ( BSX ) for $5,231,670. Following the Form 4 filing with the SEC, Fitzgerald has control over a total of 183,576 common shares of the company, with 178,342 shares held directly and 5,234 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/885725/000122520825006986/xslF345X05/doc4.xml